Abstract

This article reviews the latest updates in the classification and understanding of pediatric primary central nervous system mesenchymal tumors. It highlights changes in the World Health Organization Classification, including new tumor entities and refined prognostic criteria. Also, the review emphasizes the need for continued research to address diagnostic challenges and improve therapeutic approaches for these rare tumors.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.